Iradimed (IRMD) Revenue (2013 - 2026)

Iradimed (IRMD) has 14 years of Revenue data on file, last reported at $22.0 million in Q1 2026.

• On a quarterly basis, Revenue rose 12.65% year-over-year to $22.0 million in Q1 2026; TTM through Mar 2026 was $86.3 million, a 14.81% increase from a year earlier, with the FY2025 full-year figure at $83.8 million, up 14.43% from the prior year.
• Revenue for Q1 2026 stood at $22.0 million, down from $22.7 million in the prior quarter.
• Over the last five years, Revenue for IRMD reached as high as $22.7 million in Q4 2025 and fell as low as $12.3 million in Q1 2022.
• Historically, Revenue has averaged $17.5 million across 5 years, with a median of $17.6 million in 2024.
• Across the five-year window, Revenue surged 33.46% in 2022 and rose 10.87% in 2025, its largest moves.
• Year by year, Revenue stood at $14.9 million in 2022, then climbed by 17.42% to $17.5 million in 2023, then climbed by 11.1% to $19.4 million in 2024, then grew by 17.03% to $22.7 million in 2025, then slipped by 3.14% to $22.0 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $22.0 million in Q1 2026, $22.7 million in Q4 2025, and $21.2 million in Q3 2025.